🏛️ Verified NIH Record • Updated 2026-05-20
aPBI Re-irradiation (NCT07612254)
REPEAT: RE-irradiation With a Partial brEast, Accelerated Technique: A Single-Center, Multi-site, Prospective, Phase I/II Clinical Trial
🟡 Not Yet Recruiting Phase1 / Phase2 📋 Clinical Research Protocol Sponsor: Dartmouth-Hitchcock Medical Center
🩺 Plain-English Summary (8th-Grade Level)
This study is to determine whether acute treatment-associated adverse events following breast re-irradiation with aPBI are acceptably low and to assess local control following breast re-irradiation with aPBI. An exploratory aim is to assess cosmetic outcomes following breast re-irradiation with aPBI.
Who can join: Review the eligibility criteria below.
Location: Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
Age range: 40 Years
🧪 Interventions in This Study
- Reirradiation (RADIATION)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer Recurrent
Explore by condition: All Breast Cancer Recurrent clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.